Endo cleared to market Belbuca dissolving film painkiller
DUBLIN, Ireland, and RALEIGH, N.C. — Endo Pharmaceuticals Inc. and BioDelivery Sciences International Inc. have gained approval from the Food and Drug Administration for Belbuca buccal film (buprenorphine), an opioid treatment for chronic pain. The companies said Belbuca is the first and only buprenorphine developed with a dissolving film that is absorbed through the inner
